Literature DB >> 2401304

Neurophysiological investigations of two hundred men with erectile dysfunction. Interest of bulbocavernosus reflex and pudendal evoked responses.

M C Nogueira1, A G Herbaut, E Wespes.   

Abstract

Two-Hundred consecutive patients complaining of impotence have had complete urological and neurophysiological investigations to determine a possible organic cause of their sexual dysfunction. All patients had urological and neurological history and examination: nocturnal penile plethysmography, papaverine intracavernosus injection, penile arterial doppler and/or arteriography, cavernography-cavernometry, serum hormonal levels, and bulbocavernosus reflex (BCR). Peripheral conduction velocities and pudendal-evoked responses (PER) were also performed if neurological history or examination and/or BCR were abnormal. Only 30 patients (15%) had an abnormal BCR. In 17 patients, a neurological associated disorder was found. Four patients had normal erections during plethysmography, despite their complaints. Nine patients with an isolated prolonged BCR also presented a vascular abnormality that could explain impotence. Abnormal PER was observed only in 6 patients, 4 of them with a prolonged BCR as well. These results suggest that PER is not an interesting neurophysiological routine test for the diagnosis of neurogenic impotence and that the relationship between an abnormal BCR and neurogenic impotence is doubtful.

Entities:  

Mesh:

Year:  1990        PMID: 2401304     DOI: 10.1159/000463863

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  2 in total

1.  Corpus cavernosum electromyography (CC-EMG): a new technique in the diagnostic work-up of impotence.

Authors:  F Sasso; G Gulino; E Alcini
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  Clinical classification of cauda equina syndrome for proper treatment.

Authors:  Jiangang Shi; Lanshun Jia; Wen Yuan; GouDong Shi; Bin Ma; Bo Wang; JianFeng Wu
Journal:  Acta Orthop       Date:  2010-06       Impact factor: 3.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.